Silicon Canals
TRENDING
  • Mobility
  • AI
  • FinTech
  • Software & SaaS
No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact
No Result
View All Result
Silicon Canals
No Result
View All Result

Dutch medtech startup Momala aspires to cure malaria with rapid diagnostic tests

Aaron Mirck by Aaron Mirck
November 3, 2017
in Health & Medtech, Startups
0
Dutch medtech startup Momala aspires to cure malaria with rapid diagnostic tests
9
SHARES
LinkedInTwitterWhatsAppFacebook

Dutch medtech startup Momala aspires to help to cure malaria by making the diagnosis of the disease scalable via a mobile app. “Malaria is still a huge problem in many parts of the world. In 2016 there were 212 million cases of Malaria and 430.000 deaths. One of the core issues is the availability and quality of diagnostics”, Bouke Broeren, founder of Momala, states. 

What problem do you want to solve?

“Microscopy is still the golden standard in the Malaria diagnostic market but is not scalable due to lack of trained staff. The quality and time of a diagnosis can vary a lot with every expert. This is especially a problem in low resource environments. Rapid diagnostic tests (RDTs) are a substitute for microscopy if that is not possible. RDTs are disposable tests that often can only diagnose one species of Malaria.

 - Partner content -
Cost of software - The Software house
The cost of building software
Marek Gajda, CTO of The Software House, shares his insights on building high-quality...Show More
Marek Gajda, CTO of The Software House, shares his insights on building high-quality software. Show Less
Read more

There are a few drawbacks with RDTs. The quality of the different brands varies a lot. They also need to be transported and often stored at specific temperatures, which brings a big logistical challenge for most areas in Africa. The diagnosis of an RDT takes around 25 minutes. There are many more problems, but these are the core issues in the diagnostic field of Malaria.”

How did you think of Momala?

“MOMALA’s algorithm is based on the Ph.D. work of Dr. Syed Saiden Abbas (Syed Saiden Abbas, Ph.D. machine learning software developer, machine learning expert and inventor of MOMALA algorithm), who is employed by Orikami. Based on his Ph.D. defense, the founders of MOMALA were inspired to bring this solution to rural Africa. We have been to Africa multiple times, to research the current situation and evaluate the various problems. During these trips we came to the conclusion that the capacity for quality diagnostics are lacking. Patients have to wait and walk hours to get a proper diagnosis.

This situation can be improved with our application. We can scale the expertise to increase the capacity for quality diagnostics. The smartphone penetration is actually pretty high in Kenya (60%). Most of the smartphones that are used are not the high-end smartphones (iPhone, Samsung) but mainly lower quality smartphones.”

So, where does Momala stand today – and where do you want to go?

“At this moment the application is finished for the first clinical trial. This will start at the end of November and will take place in 6 different locations in Kenya. This will be done in cooperation with our partner Amref health Africa. We reached the Accenture awards finals in the years 2016 and 2017 and also The Spindle best innovation awards final in 2017. However, Malaria is just the tip of the iceberg. We want to become the number one method for microscopic diagnostics in Africa.

Through the same technique of diagnosing malaria, we can add more diseases to our product portfolio. Kenya will be our first focus market, but we will expand throughout Africa. We will need a lot of sales the coming years, but also an investment to scale and research and develop the potential markets and diseases.”

Momala was one of the nominees for the Accenture Innovation Awards. Do you have any tips for a successful pitch?

“Try not to put as much information as possible in the 1 minute you have. Tell the pitch calm and with enthusiasm, so that people will understand and get excited about the product. Also, read about the jury, try to imagine yourself in their situation; what would get them enthused, what makes their hearts go faster?

Doctor examining image by Shutterstock

close

Want to stay on top of the latest rounds, coolest tech and hottest startups?

Subscribe to our free, daily news blast and stay up-to-date!

Check your inbox or spam folder to confirm your subscription.

 - Partner content -
Nebula CTO Andre Witte
Cloud spend management 😱
Tracking cloud spend can be tricky. Learn from Nebula's CTO Andre Witte how to keep the...Show More
Tracking cloud spend can be tricky. Learn from Nebula's CTO Andre Witte how to keep the costs at bay in 2021. Show Less
Read more
Tags: accenture innovation awardsmalariarapid diagnostic tests
Share1Tweet2SendShare4

Featured events

07apr10:0012:30FeaturedWorkshop: pr for startupsHow to grow your startup with the help of public relations

Partner content | Work with us

Blue Tulip Awards announce 5 finalists in the Food & Water and Education & Employment theme

Impact media foundation 5 Media offers grants up to €100,000 per year to drive a sustainable future

Here’s how cryptocurrency will take over the world

Blue Tulip Awards is driven by purpose: why innovation and equality go hand in hand

Future of coding: CTOs discuss low-code versus custom code software development for their business

Breaking news from Amsterdam | Partner

Here’s why Just Eat Takeaway is expanding its offices in Amsterdam

Amsterdam-based Veylinx uses Nobel Prize-winning approach to solve the problem of unreliable survey data; raises €1.6M

Amsterdam-based fintech unicorn Mollie enters UK market to helps merchants there grow into Europe post-Brexit

Amsterdam-based HR tech Recruitee takes a “shortcut” to a future unicorn status

  • About Silicon Canals
  • Partner with Silicon Canals
  • Contact us
  • Newsletter
  • Disclaimer
  • Privacy policy
  • Terms & Conditions Silicon Canals

Silicon Canals 2014-2020 | Website: Bright Idiots

No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdam
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact

Silicon Canals 2014-2020 | Website: Bright Idiots

X

This website uses cookies to ensure the best possible experience. We may share this information with our advertising and analytics partners. By clicking 'Accept', you agree to our use of cookies and similar technologies. More info